JP Morgan Maintains Overweight on Anterix, Raises Price Target to $133
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $50 to $133.